Recent VVOS News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 09:20:10 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 09:05:24 PM
- Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 11/14/2024 09:05:00 PM
- Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call • GlobeNewswire Inc. • 11/13/2024 10:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/06/2024 09:15:11 PM
- Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association • GlobeNewswire Inc. • 10/08/2024 11:30:00 AM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/24/2024 06:59:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 12:05:23 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/20/2024 12:00:29 PM
- Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 09/19/2024 11:00:00 AM
- Healthcare Shares Pop On FDA Clearance • AllPennyStocks.com • 09/18/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 12:00:16 PM
- Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring • GlobeNewswire Inc. • 09/18/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 08:05:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 09:00:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:24:05 PM
- Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 08/14/2024 08:05:00 PM
- Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call • GlobeNewswire Inc. • 08/14/2024 11:30:00 AM
- Form 424B1 - Prospectus [Rule 424(b)(1)] • Edgar (US Regulatory) • 08/08/2024 09:19:13 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/08/2024 04:15:19 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/30/2024 10:17:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 12:00:30 PM
- Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model • GlobeNewswire Inc. • 06/27/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:15:35 PM
- Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance • GlobeNewswire Inc. • 06/12/2024 11:30:00 AM
FoodTech Trailblazer Beyond Oil Appoints New COO from KFC Amidst Massive Global Expansion (OTCQB: BEOLF) (CSE: BOIL), up 250% this year • BOIL • Nov 25, 2024 11:12 AM
UC Asset announces plan of acquisition to increase awareness for its stock trading • UCASU • Nov 25, 2024 9:30 AM
HealthLynked Receives $500,000 Payment Milestone from Sale of ACO Health Partners • HLYK • Nov 25, 2024 8:00 AM
Critical Metals Surge Opens Prime Opportunity for Mining Investors • PLG • Nov 22, 2024 8:30 AM
ILUS Agrees to Swap Majority Stake in Quality Industrial Corp. for Future Majority Stake in Fusion Fuel Green (NASDAQ: HTOO) • ILUS • Nov 20, 2024 9:07 AM
Avant Technologies and Ainnova Advancing Proprietary Retinal Camera to Market with Vision AI Software • AVAI • Nov 20, 2024 8:00 AM